Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Auris Medical completes patient enrollment in phase I/II trial with AM-101

Feb. 5, 2008

Solvay submits complete response to FDA approvable letter for Luvox CR

Feb. 5, 2008

Exercise-induced NMDA receptor activity prevents mature motor unit death in SMA

Feb. 5, 2008

Florida International University patent discloses novel free radical scavengers

Feb. 5, 2008

Escitalopram effective in treating multisomatoform disorder

Feb. 5, 2008

MediciNova's MN-166 reduces persistent black hole formation in MS

Feb. 4, 2008

FDA accepts BLA filing for Dysport in cervical dystonia

Feb. 4, 2008

M's Science initiates European phase II stroke recovery study

Feb. 4, 2008

Transtec provides a safe alternative in opioid treatment

Feb. 4, 2008

Genetic variation in drug transporter ABCB1 is linked to antidepressant efficacy

Feb. 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...